Joshua E Meyer, MD
Fox Chase Cancer Center
333 Cottman Ave
Philadelphia, PA 19111
Video: Dr. Joshua Meyer
Hepatobiliary and Pancreatic Cancer Treatment at Fox Chase Cancer Center
- Carol Hobson - Liver Cancer (Bile Duct Cancer) Patient Stories
(May 29, 2013)
Attending Physician, Radiation Oncology
Assistant Director of the Residency/Fellowship Training Program, Radiation Oncology
Gastrointestinal cancers, including pancreas, liver, esophagus, stomach, instestinal, colon, rectal, and anal cancers. I also treat lung tumors. I specialize in using stereotactic radiation to deliver short courses of radiation with the highest accuracy to well-defined targets while minimizing the risk of side effects.
American Board of Radiology, Radiation Oncology
I joined Fox Chase Cancer Center after completing my residency in radiation oncology at Weill Cornell Medical Center in New York City, having been selected Chief Resident during my final year. During my training, I was fortunate to be able to take care of patients from very diverse backgrounds, and with a variety of illnesses. I was excited to be recruited by Fox Chase to treat gastrointestinal and lung cancer patients.
I particularly enjoy the work I do because of its multidisciplinary nature. Patients with gastrointestinal and lung cancers often get chemotherapy, surgery, and radiation, and I enjoy working with the terrific physicians in other departments to come up with the best possible plan for each patient. I particularly appreciate the opportunity to take the time to explain these decisions to my patients, working to ensure that they understand the reasons behind all of the recommendations that are being made. Cancer diagnosis can be frightening, and it has been my experience that the time I spend to help my patients understand their treatment options is very helpful in easing this apprehension.
My specialties include treating patients with cancer of the pancreas, liver, esophagus, stomach, colon, rectum, and anus, in addition to lung. I also have expertise in using stereotactic radiation, meaning the delivery of short courses of radiation with the highest accuracy, while minimizing the risk of side effects to patients.
In addition to my primary role treating cancer patients, I am also pursuing research into ways that patients can be treated more effectively. My previous research, focused primarily on gastrointestinal cancers, has been presented at numerous national meetings and published in peer-reviewed scientific journals. I have also received the Roentgen Resident/Fellow Research Award from the Radiological Society of North America and was selected as a clinical fellow at the ASCO/AACR Workshop on Methods in Clinical Cancer Research in 2009. It is my goal to use my research to extend and improve the lives of my patients.
MD, University of Massachusetts Medical School, Worcester, MA, 2005
Stich Radiation Center, Weill Cornell Medical Center, New York,
Honors and Awards
Clinical Fellow, ASCO/AACR Workshop on Methods in Clinical Cancer Research, 2009;
Roentgen Resident/Fellow Research Award, 2009;
Lang Research Award, New York Hospital of Queens Residents and Fellows Day, 2009;
American Radium Society Travel Grant, 2009;
2009 ASCO Cancer Foundation Merit Award, 2009;
International Society of Gastrointestinal Oncology Conference Educational Grant, 2008
My interests are in clinical research for gastrointestinal cancers. This includes the new application of radiation technology to increase surgical resectability and cure rates. It also includes outcomes work to determine which management strategies are the most effective for these patients.
Meyer JE, Parashar B: “Nasal Cavity and Paranasal Sinuses.” In: Chao KSC, Perez CA, Brady LW (eds): 3rd Edition. Radiation Oncology: Management Decisions. Lippincott-Raven, Philadelphia, PA; 2010. in review
- Meyer JE, Parashar B: “Salivary Glands.” In: Chao KSC, Perez CA, Brady LW (eds): 3rd Edition. Radiation Oncology: Management Decisions. Lippincott-Raven, Philadelphia, PA; 2010. in review
- Meyer JE, Sherr DL. “When Less Is More, When Less Is Less: Local Excision in Early Rectal Cancer.” Gastrointest Cancer Res. 3(3): 123-4.
- Stessin AM, Meyer JE, Sherr DL. “Neoadjuvant Radiation is Associated with Improved Survival in Patients with Resectable Pancreatic Cancer: An Analysis of Data from the Surveillance, Epidemiology, and End Results (SEER) Registry.” Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1128-33.
- FitzGerald TJ, Jodoin MB, Tillman G, Aronowitz J, Pieters R, Balducci S, Meyer J, Cicchetti MG, Kadish S, McCauley S, Sawicka J, Urie M, Lo YC, Mayo C, Ulin K, Ding L, Britton M, Huang J, Arous E. “Radiation Therapy Toxicity to the Skin.” Dermatol Clin. 2008 Jan;26(1):161-72.
- FitzGerald TJ, Aronowitz J, Cicchetti MG, Fisher G, Kadish S, Lo YC, Mayo C, McCauley S, Meyer J, Pieters R, Sherman A. “The effect of radiation therapy on normal tissue function.”
Hematol Oncol Clin North Am. 2006 Feb;20(1):141-63.
- FitzGerald TJ, Simon E, Meyer J. “Prostate carcinoma: opportunities for translational research.”
J Cell Biochem. 2004 Feb 15;91(3):433-42.
- Ganju RK, Brubaker SA, Meyer J, Dutt P, Yang Y, Qin S, Newman W, Groopman JE. “The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways.” J Biol Chem. 1998 Sep 4;273(36):23169-75.
- Parashar B, Wernicke G, Meyer JE, Ballas L, Shah A, Sabbas A, Nori D, Chao K, “Excisional Biopsy Followed By Intra-operative Seed Implant Is A Promising Alternative To Stereotactic Radiotherapy (SRT) For Solitary Lung Cancer (SLC).” (Accepted, American Society for Radiation Oncology 51st Annual Meeting Poster Presentation, Chicago, IL, November 1-5, 2009)
- Meyer JE, Rutledge JR, Nori D, “Radiation Therapy Increases Survival in Surgically Treated Localized Invasive Thymomas and Thymic Carcinomas: An Analysis of the SEER Database.” (American Radium Society 91st Annual Meeting, Oral Presentation, Vancourver, BC, Canada, April 25-29, 2009)
- Meyer JE, Sherr DL, Schnoll-Sussman FH, Pochapin MB, Christos PJ. “Incidence of rectal cancer in patients under age 40: An analysis of the SEER database.” (2009 Gastrointestinal Cancers Symposium Poster Presentation, San Francisco, CA, January 15-17, 2009)
- Meyer JE, Sherr DL, Schnoll-Sussman FH, Pochapin MB, Christos PJ. “Increasing Incidence of rectal cancer in patients under age 40: An analysis of the SEER database.” (5th Annual International Society of Gastrointestinal Oncology Conference Oral Presentation, Arlington, VA, September 25-27, 2008.
- Singh R, Meyer JE, Christos P, Sherr DL. “Predictive Factors for a Pathologic Complete Response in Patients Receiving Preoperative Chemoradiation for Locally Advanced Rectal Cancer.” (American Society of Therapeutic Radiation Oncology 50th Annual Meeting Poster Presentation, Boston, MA, September 21-25, 2008)
- Parashar B, Chi K, Meyer JE, Sabbas A, Nori D, “Importance of contouring the cervical spine levels in IMRTradiation for head and neck cancers: Implications for re-irradiation.” (European Society for Therapeutic Radiology and Oncology Annual Congress: ESTRO 27, Göteberg, Sweden, September 14 – 18, 2008)
- Stessin AM, Meyer JE, Sherr DL. “Pre-Operative Radiation is Associated with Improved Survival in Patients with Resectable Pancreatic Cancer: Analysis of Data from the Surveillance, Epidemiology, and End Results (SEER) Registry.” (American Society of Therapeutic Radiation Oncology 49th Annual Meeting Poster Presentation, Los Angeles, CA, October 28 – November 1, 2007)
- Mendenhall NP, Meyer J, Williams J, Tebbi C, Kessel S, Laurie F, Fitzgerald TJ. ”The Impact of Central Quality Assurance Review Prior to Radiation Therapy on Protocol Compliance: POG 9426, a Trial in Pediatric Hodgkin’s Disease.” (American Society of Hematology 47th Annual Meeting Poster Presentation, Atlanta, GA, December 10-13, 2005)
- Meyer JE, Fitzgerald TJ, Altieri DC. “Irradiation upregulates EGFR and survivin in non small cell lung cancer cells.” (Radiation Research Society 2005 Annual Meeting Poster Presentation, Denver, CO, October 16-19, 2005)